Induction chemotherapy in metastatic neuroblastoma--does dose influence response? A critical review of published data standards, options and recommendations (SOR) project of the National Federation of French Cancer Centres (FNCLCC).

Induction chemotherapy in metastatic neuroblastoma--does dose influence response? A critical review of published data standards, options and recommendations (SOR) project of the National Federation of French Cancer Centres (FNCLCC).

Item
http://www.wikidata.org/entity/Q30611207
Rapid COJEC versus standard induction therapies for high-risk neuroblastomaPrediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma.PGK1 as predictor of CXCR4 expression, bone marrow metastases and survival in neuroblastoma.Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12Stage 4 neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatment.Schedule-dependent response of neuroblastoma cell lines to combinations of etoposide and cisplatin.Improved antitumour immunity in murine neuroblastoma using a combination of IL-2 and IL-12.The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis.Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastineTreatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study.Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFalpha.c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.Aminophosphine ligands as a privileged platform for development of antitumoral ruthenium(ii) arene complexes.Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma.
P2860

Induction chemotherapy in metastatic neuroblastoma--does dose influence response? A critical review of published data standards, options and recommendations (SOR) project of the National Federation of French Cancer Centres (FNCLCC).

Item
http://www.wikidata.org/entity/Q30611207
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Induction chemotherapy in meta ...... rench Cancer Centres (FNCLCC).
@ast
Induction chemotherapy in meta ...... rench Cancer Centres (FNCLCC).
@en
type
label
Induction chemotherapy in meta ...... rench Cancer Centres (FNCLCC).
@ast
Induction chemotherapy in meta ...... rench Cancer Centres (FNCLCC).
@en
prefLabel
Induction chemotherapy in meta ...... rench Cancer Centres (FNCLCC).
@ast
Induction chemotherapy in meta ...... rench Cancer Centres (FNCLCC).
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Induction chemotherapy in meta ...... rench Cancer Centres (FNCLCC).
@en
P2093
P304
P31
P356
10.1016/S0959-8049(00)00189-1
P433
P478
P577
P698
P921